We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Name | Symbol | Market | Type |
|---|---|---|---|
| Novartis AG | NYSE:NVS | NYSE | Depository Receipt |
| Price Change | % Change | Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.09 | 0.09% | 97.43 | 97.91 | 97.07 | 97.75 | 525,654 | 17:36:30 |
From May 2019 to May 2024
GlaxoSmithKline PLC is selling its remaing rights to an autoimmune disease treatment to Novartis AG. "Glaxa Sells Rights to Auto-Immune Drug to Novartis," at 0934 GMT, misspelled Glaxo's name in the headline.
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
(END) Dow Jones Newswires
August 21, 2015 09:11 ET (13:11 GMT)
Copyright (c) 2015 Dow Jones & Company, Inc.
1 Year Novartis Chart |
1 Month Novartis Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
